Shoaib Muhammad Harris, Ahmed Farrukh Rafiq, Yousuf Rabia Ismail, Siddiqui Fahad, Saleem Muhammad Talha, Qazi Faaiza, Khan Momina Zarish, Irshad Asma, Bashir Lubna, Naz Shazia, Farooq Muhammad, Mahmood Zafar Alam
Department of Pharmaceutics, Faculty of Pharmacy and Pharmaceutical Sciences, University of Karachi, Karachi, Sindh, Pakistan.
Department of Pharmaceutics, Faculty of Pharmacy, Federal Urdu University of Arts, Science and Technology, Karachi, Pakistan.
Front Pharmacol. 2023 Mar 3;14:1066018. doi: 10.3389/fphar.2023.1066018. eCollection 2023.
A SeDeM expert tool-driven I-optimal mixture design has been used to develop a directly compressible multiparticulate based extended release minitablets for gastro-retentive drug delivery systems using loxoprofen sodium as a model drug. Powder blends were subjected to stress drug-excipient compatibility studies using FTIR, thermogravimetric analysis, and DSC. SeDeM diagram expert tool was utilized to assess the suitability of the drug and excipients for direct compression. The formulations were designed using an I-optimal mixture design with proportions of methocel K100M, ethocel 10P and NaHCO as variables. Powder was compressed into minitablets and encapsulated. After physicochemical evaluation lag-time, floating time, and drug release were studied. Heckel analysis for yield pressure and accelerated stability studies were performed as per ICH guidelines. The PBPK Advanced Compartmental and Transit model of GastroPlus™ was used for predicting pharmacokinetic parameters. Drug release follows first-order kinetics with fickian diffusion as the main mechanism for most of the formulations; however, a few formulations followed anomalous transport as the mechanism of drug release. The -based pharmacokinetic revealed relative bioavailability of 97.0%. SeDeM expert system effectively used in QbD based development of encapsulated multiparticulates for once daily administration of loxoprofen sodium having predictable bioavailability.
一种基于SeDeM专家工具驱动的I-最优混合设计,已被用于开发一种直接可压片的多颗粒型缓释迷你片,用于胃滞留给药系统,以洛索洛芬钠作为模型药物。使用傅里叶变换红外光谱(FTIR)、热重分析和差示扫描量热法(DSC)对粉末混合物进行了药物-辅料应力相容性研究。利用SeDeM图专家工具评估药物和辅料用于直接压片的适用性。采用I-最优混合设计,以甲基纤维素K100M、乙基纤维素10P和碳酸氢钠的比例为变量进行配方设计。将粉末压制成迷你片并进行包衣。在进行物理化学评价后,研究了滞后时间、漂浮时间和药物释放情况。按照国际人用药品注册技术协调会(ICH)指南进行了产率压力的赫克尔分析和加速稳定性研究。使用GastroPlus™的PBPK高级房室和转运模型预测药代动力学参数。大多数配方的药物释放遵循一级动力学,以菲克扩散为主要机制;然而,少数配方以异常转运作为药物释放机制。基于该模型的药代动力学显示相对生物利用度为97.0%。SeDeM专家系统有效地用于基于质量源于设计(QbD)的包衣多颗粒制剂的开发,用于每日一次给药的洛索洛芬钠,其具有可预测的生物利用度。